Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical and genomic signatures of SARS-CoV-2 Delta breakthrough infections in New York

26 Jul 2022

Abstract excerpt

BACKGROUND: In 2021, Delta became the predominant SARS-CoV-2 variant worldwide. While vaccines have effectively prevented COVID-19 hospitalization and death, vaccine breakthrough infections increasingly occurred. The precise role of clinical and genomic determinants in Delta infections is not known, and whether they contributed to increased rates of breakthrough infections compared to unvaccinated controls....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19 Clinical Research Studies
Share to Immune responses and vaccinations
Share to SARS-CoV-2 and COVID-19 Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35906172
DOI: 10.1016/j.ebiom.2022.104141

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical and genomic signatures of SARS-CoV-2 Delta breakthrough infections in New YorkPMID 35906172Read ↗

Clinical and genomic signatures of rising SARS-CoV-2 Delta breakthrough infections in New YorkSemantic proximity Read ↗

Delta variants of SARS-CoV-2 cause significantly increased vaccine breakthrough COVID-19 cases in Houston, TexasSemantic proximity Read ↗

Dominance of Alpha and Iota variants in SARS-CoV-2 vaccine breakthrough infections in New York City.Semantic proximity Read ↗

SARS-CoV-2 vaccine Alpha and Delta variant breakthrough infections are rare and mild, but happen relative early after vaccinationSemantic proximity Read ↗

SARS-CoV-2 vaccine breakthrough by Omicron and Delta variants: comparative assessments with New York State genomic surveillance dataSemantic proximity Read ↗

Duration of viral shedding and culture positivity with post-vaccination breakthrough delta variant infectionsSemantic proximity Read ↗

SARS-CoV-2 Delta vaccine breakthrough transmissibility in Alachua, FloridaSemantic proximity Read ↗

Infection with the SARS-CoV-2 Delta Variant is Associated with Higher Infectious Virus Loads Compared to the Alpha Variant in both Unvaccinated and Vaccinated IndividualsSemantic proximity Read ↗

Transmission event of SARS-CoV-2 Delta variant reveals multiple vaccine breakthrough infectionsSemantic proximity Read ↗

Surveillance genome sequencing reveal multiple SARS-CoV-2 variants circulating in the central Texas, USA with a predominance of Delta variant and review of vaccine breakthrough casesSemantic proximity Read ↗

SARS-CoV-2 Vaccine Breakthrough by Omicron and Delta Variants, New York, USASemantic proximity Read ↗

Investigating SARS-CoV-2 breakthrough infections per variant and vaccine typeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.